Description
Omacetaxine Mepesuccinate, marketed under the brand name SYNRIBO, It is an prescription medication that has been approved omacetaxine mepesuccinate (brand name Synribo) on October 26, 2012. The FDA granted accelerated approval for this drug to treat adult patients with chronic or accelerated phase chronic myeloid leukemia (CML).
What is SYNRIBO (omacetaxine mepesuccinate) ?
SYNRIBO for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia
(CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate.
There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.
How to order approved “SYNRIBO (omacetaxine mepesuccinate) for Injection” Medicine?
SYNRIBO (Omacetaxine Mepesuccinate) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing SYNRIBO and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
